San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... The biotech discontinued two Phase 1/2 trials of its lead cancer drug ...
News
- Bicycle Therapeutics cuts 30% of workforce as it winds down lead cancer drug - Boston ...
- TSHA Announces Second Annual Texas Revolution Rendezvous in San Antonio This April
Following a successful inaugural year, the event returns to the legendary Menger Hotel in San Antonio, located just steps away from the Alamo.
- New Case Study: bioAffinity Technologies' CyPath® Lung Provides Actionable Results and ...
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for ...
- TSHA Announces Second Annual Texas Revolution Rendezvous in San Antonio This April
SAN ANTONIO, TX, UNITED STATES, March 17, 2026 /EINPresswire.com/ — The ... biomedical innovation to strengthen U.S. healthcare supply. March ...
- Engineering team deliberates on ethics during case competition - The Paisano
Despite UT San Antonio not participating in the competition for the past six years, junior biomedical engineering major Christian Unogu, senior ...